Georgia Power Restores Power to Over 1.3M Customers Following Hurricane Helene
Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Johnson & Johnson Halts Mid-stage Study for Dengue Antiviral
Nvidia, Trade Desk And A Financial Stock On CNBC's 'Final Trades'
Duke to Delay Shutting Largest Coal-fired Plant as Climate Goals Succumb to Reality
Why S&P 500's Year-Long Overbought Signal Has This Expert Talking, Plus 3 Stocks To Watch
Wells Fargo's 'Core' Stocks: GOOGL, HD, KO, and More
BofA's Top 10 Value Stocks for October
10 Dividend Stocks for Stability and Safety
GE Aerospace To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
U.S. Tweaks 2025 Medicare Price Negotiation Process
B of A Securities Maintains Underperform on CME Gr, Raises Price Target to $180
CME Gr Analyst Ratings
Southern Analyst Ratings
Johnson & Johnson's Options: A Look at What the Big Money Is Thinking
Companies Heavily Investing in AI Have Low Quant Valuation Grades
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Johnson & Johnson Presents Results From Study Showing That ERLEADA Demonstrates Statistically Significant And Clinically Meaningful Improvement In Overall Survival Compared To Enzalutamide In Patients With Metastatic Castration-sensitive Prostate Cancer
J&J Submits Supplemental BLA for Darzalex Faspro to FDA
Utilities Outpace S&P 500, Fueled By AI: These 2 Stocks Lead The Charge